Skip to main content
Toggle navigation
Search
Home
Preview Program
Poster Schedule
Home
Poster Schedule
All Days
Fri, Apr 25
Sat, Apr 26
Poster Schedule
Type here to filter the list
Friday, April 25, 2025
9:45 AM – 1:15 PM
(1) Racial Disparities in Urine Toxicology Screening for Labor and Delivery Admissions
Favorite
9:45 AM – 1:15 PM
(2) Race and Insurance Influence on Medications for Opioid Use Disorder
Favorite
9:45 AM – 1:15 PM
(3) Leveraging Asian American & Pacific Islander Resilience in Substance Use Recovery
Favorite
9:45 AM – 1:15 PM
(4) MOUD Treatment Receipt and Retention by Sociodemographics at a Safety-Net Health-System
Favorite
9:45 AM – 1:15 PM
(5) Substance Treatment Phone Line Expansion Improves Connection to Treatment and Resources
Favorite
9:45 AM – 1:15 PM
(6) Scaling Up Low Barrier Wound Care for People who Use Drugs
Favorite
9:45 AM – 1:15 PM
(7) Xylazine Positivity Rate Among Patients at an Urban Low-Barrier Access Clinic
Favorite
9:45 AM – 1:15 PM
(8) Tianeptine “Gas Station Heroin” Products: Public Health Concern or Niche Substance Use?
Favorite
9:45 AM – 1:15 PM
(9) A Drug Identification Program as a Harm Reduction Initiative
Favorite
9:45 AM – 1:15 PM
(10) Exploring Street Medicine's Acceptability: A Qualitative Study of Team Member Perspectives
Favorite
9:45 AM – 1:15 PM
(11) Harm Reduction Vending Machines Increase Equitable Access to Naloxone and Health Supplies
Favorite
9:45 AM – 1:15 PM
(12) Implementing an Opioid Overdose Prevention Program within a Community Mental Health Clinic
Favorite
9:45 AM – 1:15 PM
(13) Implementation Determinants of Harm Reduction Integration in Outpatient Clinical Settings
Favorite
9:45 AM – 1:15 PM
(14) Physician Perspectives on Initiating Treatment of Hepatitis C during Hospitalization
Favorite
9:45 AM – 1:15 PM
(15) Discharge on MOUD Reduces Relapse in Trauma Patients with Prior Opioid Dependence
Favorite
9:45 AM – 1:15 PM
(16) Recovery Capital among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder
Favorite
9:45 AM – 1:15 PM
(17) Attitudes of Patients Who Use Drugs Towards Policies Regarding In-Hospital Use
Favorite
9:45 AM – 1:15 PM
(18) Barriers to Prescribing Varenicline and NRT in Inpatient Psychiatric Settings
Favorite
9:45 AM – 1:15 PM
(19) Impact of Mental Health Conditions and Psychiatric Prescriptions on MOUD at Discharge
Favorite
9:45 AM – 1:15 PM
(20) Emergency Department Utilization for OUD Before and After Receiving Buprenorphine from EMS
Favorite
9:45 AM – 1:15 PM
(21) Advancing the Evidence on Emergency Department and Hospital Linkage to Methadone Treatment
Favorite
9:45 AM – 1:15 PM
(22) Secondary Outcomes from the START RCT to Improve OUD Care for Inpatients
Favorite
9:45 AM – 1:15 PM
(23) Needle-Free Lidocaine Administration Before XR-BUP Decreases Patient Perceived Pain Score
Favorite
9:45 AM – 1:15 PM
(24) Prevalence of ADHD in Adults Seeking Methadone Treatment for Opioid Use Disorder
Favorite
9:45 AM – 1:15 PM
(25) Clinical Characteristics Differences Between Sexual Minorities and Heterosexuals with OUD
Favorite
9:45 AM – 1:15 PM
(26) Factors Associated with Drug Harm Reduction Among Electronic Dance Music Event Attendees
Favorite
9:45 AM – 1:15 PM
(27) Improving Methadone Access: Creating a Reliable Methadone Clinic Database in Los Angeles
Favorite
9:45 AM – 1:15 PM
(28) Quetiapine, A Novel Additive to the Illicit Heroin Supply in Los Angeles
Favorite
9:45 AM – 1:15 PM
(29) Emergence of Local Anesthetics in the Los Angeles Illicit Fentanyl Supply
Favorite
9:45 AM – 1:15 PM
(30) Coping with Crisis: Housing Instability, Food Insecurity, and Cannabis Use in Pregnancy
Favorite
9:45 AM – 1:15 PM
(31) Hepatitis C Virus Care Linkage for Peripartum Individuals with Opioid Use Disorder
Favorite
9:45 AM – 1:15 PM
(32) Maternal Attachment Moderates Effects of Substance Use on White-Matter Microstructure
Favorite
9:45 AM – 1:15 PM
(33) Perinatal Quality Collaboratives: Supporting People with Substance Use Disorders
Favorite
9:45 AM – 1:15 PM
(34) A Longitudinal Analysis of PrEP Eligibility Among Women who Inject Drugs
Favorite
9:45 AM – 1:15 PM
(35) Breaking Barriers: Social Vulnerability and Retention among Pregnant Women with Opioid Use
Favorite
9:45 AM – 1:15 PM
(36) National Estimates of Alcohol Use Disorder Diagnosis and Treatment in Pregnancy, 2006-2019
Favorite
9:45 AM – 1:15 PM
(37) Impact of Integrated Substance Use and Obstetric Care on Delivery Outcomes
Favorite
9:45 AM – 1:15 PM
(38) Treatment History among Patients with Recurrent Opioid Overdoses: A Multicenter Study
Favorite
9:45 AM – 1:15 PM
(39) Self-Harm as a Contributor to the “Fourth Wave”: Suicidality in Stimulant Overdoses
Favorite
9:45 AM – 1:15 PM
(40) Family History Density: Impact on Participant Substance Use Onset and Duration
Favorite
9:45 AM – 1:15 PM
(41) Semaglutide as a Potential Breakthrough in Treatment of Alcohol Use Disorder
Favorite
9:45 AM – 1:15 PM
(42) Machine Learning to Assess Stimulant Therapy Risk for Stimulant Use Disorder
Favorite
9:45 AM – 1:15 PM
(43) Innovative Interprofessional Education Model for Substance Use Disorder Care
Favorite
9:45 AM – 1:15 PM
(44) Opioid Use Disorder Medication Accessibility in Central and Outlying Texas Counties
Favorite
9:45 AM – 1:15 PM
(45) Age, Symptom Management, and Cannabis Use Disorder Risk: A Cross-Sectional Study
Favorite
9:45 AM – 1:15 PM
(46) Provider Experiences of SUD Management in Pediatric Hospitals: A Qualitative Study
Favorite
9:45 AM – 1:15 PM
(47) Neuromodulation in Transitional Age Youth Substance Use Disorders: A Narrative Review
Favorite
9:45 AM – 1:15 PM
(48) Perceived Need for Treatment Among Adults With Severe Substance Use Disorder
Favorite
9:45 AM – 1:15 PM
(49) Reimagining SBIRT: Provider, Adolescent, and Caregiver Perceptions in Primary Care
Favorite
9:45 AM – 1:15 PM
(50) Evaluating Adolescent Medicine Providers’ Barriers to SUD Screening and Intervention
Favorite
9:45 AM – 1:15 PM
(51) Elevating Patient Voices: Substance Use Care, Recovery Support, & Overdose Prevention
Favorite
9:45 AM – 1:15 PM
(52) Barriers to Healthcare Utilization and Adolescent Prescription Drug Misuse During COVID-19
Favorite
9:45 AM – 1:15 PM
(53) Pharmacy Barriers to Receiving Buprenorphine Addiction Treatment Through Telehealth
Favorite
9:45 AM – 1:15 PM
(54) Determinants of Increased Travel Burden for Patients Treated with Buprenorphine
Favorite
9:45 AM – 1:15 PM
(55) Who Gets Treatment? Substance Use Disorder Treatment Enrollment after Traumatic Injury
Favorite
9:45 AM – 1:15 PM
(56) Bromazolam Withdrawal Requiring ICU Admission: Case Report of Designer Benzodiazepine Use
Favorite
9:45 AM – 1:15 PM
(57) Impact of Gabapentin Regulation on Opioid Overdose Trends, 2013-2022
Favorite
9:45 AM – 1:15 PM
(58) Assessing Readability and Stigma of ChatGPT’s Opioid Use Disorder FAQs
Favorite
9:45 AM – 1:15 PM
(59) Protracted Benzodiazepine Withdrawal in a Psychiatric Patient with Polysubstance Use
Favorite
9:45 AM – 1:15 PM
(60) Low-Dose Dexmedetomidine: Repurposing an Intravenous Agent for Opioid & Alpha 2 Withdrawal
Favorite
9:45 AM – 1:15 PM
(61) Opioid Withdrawal and Autonomic Complications Associated with Medetomidine Adulteration
Favorite
9:45 AM – 1:15 PM
(62) Buprenorphine for Naltrexone-XR-Precipitated Opioid Withdrawal
Favorite
9:45 AM – 1:15 PM
(63) Addressing Gaps in Buprenorphine Treatment Among Black and Non-English-Speaking Patients
Favorite
9:45 AM – 1:15 PM
(64) Polymicrobial Bacteremia from Licking Syringe Plungers: A Case Report and Scoping Review
Favorite
9:45 AM – 1:15 PM
(65) Kratom and Kava Use Disorder & Withdrawal Management: A Case Study
Favorite
9:45 AM – 1:15 PM
(66) Recognizing Nitrous Oxide Toxicity: Key Neuropsychiatric Symptoms and Diagnostic Clues
Favorite
9:45 AM – 1:15 PM
(67) Sustained Positive Buprenorphine after LAIs and Naltrexone Micro-Dosing in Treating OUD
Favorite
9:45 AM – 1:15 PM
(68) Improving Lives, Saving Money: Housing Solutions for Substance Use Disorders
Favorite
9:45 AM – 1:15 PM
(69) Breaking the Cycle: Life Saving ICD in Methadone-Induced Torsades de Pointes
Favorite
